January/February 2019
Biopharma Asia
January/February 2019 | Volume 8 Issue 1
Integrity Assurance for SUS: End-User Perspective
Charlotte Masy, Project Manager in Global Support Jean-Yves Bauer, Senior Engineer GSK Vac...
Biologics Production: Impact of Degrading or Modifying Impurities Resulting from Microbial...
Friedrich von Wintzingerode, PhD, Senior Manager, Global QC Microbiology Markus Haberger, ...
Assessing possibilities and preventing the risk of using disposables
Berthold Bodeker, Chief Scientist Bayer Pharma AG
Supercritical Fluid Chromatography (SFC) in the pharmaceutical industry
Larry Miller, Principal Scientist Amgen
Choosing the Right Technology for the Right Problems
Pall Biotech
















